Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |